Submit Deal

BIOCON BIOLOGICS LTD

HQ - Bengaluru

Summary

Biocon Biologics operates as a biopharmaceutical company. The Company offers treatment for chronic diseases such as diabetes, oncology, cancer, and autoimmune diseases. Biocon Biologics India serves customers worldwide.

Deals Overview

Total Deals7

Valued Deals7

Total Value£ 3.49 B

Avg. Deal Size£ 498 M

Market Context

Senior Management

Christiane Hamacher
CEO
Shreehas Tambe
CEO & Managing Director
Siddharth Mittal
CEO

Sort

viatris (biosimilars assets)

HQ - United States

Biotechnology

29 Nov 2022

Investment Date

100%

Stake

£ 2.49 B

Deal Value

syngene

HQ - India

Biotechnology

7 Sep 2022

Investment Date

Stake

£ 136 M

Deal Value

biocon biologics (indian branded formulations business unit)

HQ - India

Biotechnology

2 Apr 2024

Investment Date

100%

Stake

£ 117 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy